Gå direkt till huvudinnehållet

P/S-Proteinelektrofores

Senast reviderad:
Sakkunnig:
  • Nilsson-Ehle P (red.). Laurells klinisk kemi i praktisk medicin. Lund: Studentlitteratur, 2012.
  1. O'Connell TX, Horita TJ, Kasravi B. Understanding and interpreting serum protein electrophoresis. Am Fam Physician 2005; 71: 105-12. PubMed  
  2. Bigos SJ, et al. Acute low back problems in adults. Rockville, Md.: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1994; clinical practice guideline no. 14, AHCPR publication no. 95-0642.
  3. Kyle RA. Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 1999; 123: 114-8. PubMed  
  4. George ED, Sadovsky R. Multiple myeloma: recognition and management. Am Fam Physician 1999; 59: 1885-94. American Family Physician  
  5. Kyle RA. The monoclonal gammopathies. Clin Chem 1994; 40: 2154-61. PubMed  
  6. Boccadoro M, Pileri A. Diagnosis, prognosis, and standard treatment of multiple myeloma. Hematol Oncol Clin North Am 1997; 11: 111-31. PubMed  
  7. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc 2001; 76: 476-87. PubMed  
  8. Wallach JB. Interpretation of diagnostic tests. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 78-83.
  9. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proc 2003; 78: 21-33. PubMed  
  10. Alexanian R, Weber D, Liu F. Differential diagnosis of monoclonal gammopathies. Arch Pathol Lab Med 1999; 123: 108-13. PubMed  
  11. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564-9. New England Journal of Medicine  
  • Anders Kallner, docent och fd överläkare, Karolinska universitetslaboratoriet, Karolinska universitetssjukhuset